Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells.
Davies DM, Foster J, Van Der Stegen SJ, Parente-Pereira AC, Chiapero-Stanke L, Delinassios GJ, Burbridge SE, Kao V, Liu Z, Bosshard-Carter L, Van Schalkwyk MC, Box C, Eccles SA, Mather SJ, Wilkie S, Maher J.
Davies DM, et al. Among authors: maher j.
Mol Med. 2012 May 9;18(1):565-76. doi: 10.2119/molmed.2011.00493.
Mol Med. 2012.
PMID: 22354215
Free PMC article.